Evidence map›Paper›PMID 31924502›Full record

ArticleTicks and tick-borne diseases2020

Ixodes scapularis saliva components that elicit responses associated with acquired tick-resistance.

Sukanya Narasimhan, Cheyne Kurokawa, Husrev Diktas, Norma Olivares Strank, Jiří Černý, Kristen Murfin, Yongguo Cao, Geoff Lynn, Jos Trentleman, Ming-Jie Wu and 5 more

Open access · greenAbstract read
In one paragraph

Article in Ticks and tick-borne diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Pathogens (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Repeated Tick Infestations ImpairPathogens (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Identification of microRNAs in the Lyme Disease VectorInternational journal of molecular sciences · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Sukanya NarasimhanSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States. Electronic address: sukanya.narasimhan@yale.edu.
Cheyne KurokawaSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States.
Husrev DiktasSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States.
Norma Olivares StrankSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States.
Jiří ČernýSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States.
Kristen MurfinSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States.
Yongguo CaoSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States; Key Laboratory for Zoonosis Research, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun, 130062, People's Republic of China.
Geoff LynnSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States.
Jos TrentlemanAmsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity, Amsterdam, the Netherlands.
Ming-Jie WuSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States.
Kathy DePonteSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States.
Fred KantorSection of Allergy and Clinical Immunology, Department of Internal Medicine, New Haven, CT, 06520, United States.
Juan AnguitaCenter for Cooperative Research in Biosciences (CIC bioGUNE), Derio, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
Joppe HoviusAmsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity, Amsterdam, the Netherlands.
Erol FikrigSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06420, United States; Howard Hughes Medical Institute. Chevy Chase, MD, 20815, United States. Electronic address: erol.fikrig@yale.edu.
Yale University · USAmsterdam University Medical Centers · NLIkerbasque · ESJilin University · CNUniversity of Amsterdam · NL

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
IMMUNOHEMATOLOGY/TRANSFUSION MEDICINE RESEARCH TRAININGT32HL007974 · NHLBI · YALE UNIVERSITY · PI JEANNE E HENDRICKSON, Diane S Krause · 2001 to 2026
$8.1M
Investigations of Lyme spirochete transmission as a complex network of microbial and ecological interactionsR01GM148992 · NIGMS · UNIVERSITY OF RHODE ISLAND · PI COURET, JANNELLE, LORD, CYNTHIA C · 2022 to 2025
$2.3M
Targets of Acquired Tick-Resistance As Anti-Tick VaccinesR41AI145778 · NIAID · L2 DIAGNOSTICS, LLC · PI NARASIMHAN, SUKANYA · 2019 to 2020
$597k
Importance of Immunogenic salivary glycans in eliciting resistance to ticksR21AI128182 · NIAID · YALE UNIVERSITY · PI NARASIMHAN, SUKANYA · 2017 to 2018
$469k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS T32 HL007974NIAID NIH HHS R21 AI128182NIAID NIH HHS R41 AI145778NIGMS NIH HHS R01 GM148992
6 · The paper itself

Abstract

Ticks and tick-borne diseases are on the rise world-wide and vaccines to prevent transmission of tick-borne diseases is an urgent public health need. Tick transmission of pathogens to the mammalian host occurs during tick feeding. Therefore, it is reasoned that vaccine targeting of tick proteins essential for feeding would thwart tick feeding and consequently prevent pathogen transmission. The phenomenon of acquired tick-immunity, wherein, repeated tick infestations of non-natural hosts results in the development of host immune responses detrimental to tick feeding has served as a robust paradigm in the pursuit of tick salivary antigens that may be vaccine targeted. While several salivary antigens have been identified, immunity elicited against these antigens have only provided modest tick rejection. This has raised the possibility that acquired tick-immunity is directed against tick components other than tick salivary antigens. Using Ixodes scapularis, the blacklegged tick, that vectors several human pathogens, we demonstrate that immunity directed against tick salivary glycoproteins is indeed sufficient to recapitulate the phenomenon of tick-resistance. These observations emphasize the utility of tick salivary glycoproteins as viable vaccine targets to thwart tick feeding and direct our search for anti-tick vaccine candidates.

Indexed as

AnimalsArthropod ProteinsFemaleGlycoproteinsGuinea PigsIxodesNymphRabbitsSalivaArthropod ProteinsGlycoproteinsAcquired tick-immunityGlycoproteinsIxodes scapularisSalivary proteins

Identifiers

PMID31924502
PMCPMC7382422
OpenAlexW2997072538

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.